TFX logo

Teleflex Incorporated (TFX)

$157.10

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on TFX

Market cap

$6.23B

EPS

8.53

P/E ratio

--

Price to sales

3.25

Dividend yield

0.866%

Beta

0.855404

Price on TFX

Previous close

$155.10

Today's open

$155

Day's range

$154.63 - $157.65

52 week range

$100.18 - $157.65

Profile about TFX

CEO

Stuart Randle

Employees

15500

Headquarters

Wayne, PA

Exchange

New York Stock Exchange

Shares outstanding

39661261

Issue type

Common Stock

TFX industries and sectors

Healthcare

Medical Equipment & Supplies

News on TFX

Teleflex: The Market Is Pricing The Transition, Not The Company Coming Out Of It

Teleflex is undergoing a portfolio overhaul, with future earnings driven by cost cuts, deleveraging, and share buybacks rather than top-line growth. TFX's adjusted gross margin reached 66.8% in Q3; management raised 2026 adjusted EPS guidance to $7.50–$7.75, viewing this as a minimum. Freesolve and Ezplaz offer significant growth optionality, with Freesolve expanding in the U.S. and Ezplaz targeting a $200M+ market opportunity.

news source

Seeking Alpha • Nov 13, 2026

news preview

Teleflex to Present at the Jefferies Global Healthcare Conference in London

WAYNE, Pa.--(BUSINESS WIRE)--Management of Teleflex Incorporated (NYSE: TFX) is scheduled to speak at the Jefferies Global Healthcare Conference in London on Wednesday, November 18, 2026, at 12:00 p.m. (GMT). A live audio webcast of the conference presentation will be available on the investor section of the Teleflex website at teleflex.com. About Teleflex Incorporated As a global provider of medical technologies, Teleflex is driven by our purpose to improve the health and quality of people's l.

news source

Business Wire • Nov 11, 2026

news preview

Teleflex Q3 Earnings Call Highlights

Teleflex NYSE: TFX raised its 2026 adjusted earnings outlook after reporting higher third-quarter earnings and a return to growth in its Interventional business, although the company said a planned divestiture could close later than expected.

news source

MarketBeat • Nov 8, 2026

news preview

Teleflex Incorporated (TFX) Q3 2026 Earnings Call Transcript

Teleflex Incorporated (TFX) Q3 2026 Earnings Call Transcript

news source

Seeking Alpha • Nov 5, 2026

news preview

Teleflex Reports Third Quarter Financial Results and Full Year 2026 Outlook

WAYNE, Pa.--(BUSINESS WIRE)--Teleflex Incorporated (NYSE: TFX) (the “Company”) today announced financial results for the third quarter ended September 30, 2026. Third quarter 2026 continuing operations financial summary1 Revenue from continuing operations of $567.8 million, up 0.2% compared to the prior year period, and up 3.0% on a pro forma adjusted constant currency basis1,2 GAAP diluted EPS from continuing operations of $1.30, compared to $(1.32) in the prior year period Adjusted diluted EP.

news source

Business Wire • Nov 5, 2026

news preview

Teleflex Announces Quarterly Dividend

WAYNE, Pa.--(BUSINESS WIRE)--Teleflex Incorporated (NYSE: TFX) announced today that its Board of Directors declared a quarterly cash dividend of thirty-four cents ($0.34) per share of common stock. The dividend is payable December 31, 2026, to shareholders of record at the close of business on November 16, 2026.About Teleflex IncorporatedAs a global provider of medical technologies, Teleflex is driven by our purpose to improve the health and quality of people's lives. Through our vision to becom.

news source

Business Wire • Nov 5, 2026

news preview

Teleflex (TFX) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

While the top- and bottom-line numbers for Teleflex (TFX) give a sense of how the business performed in the quarter ended September 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

news source

Zacks Investment Research • Nov 5, 2026

news preview

Teleflex (TFX) Q3 Earnings Surpass Estimates

Teleflex (TFX) came out with quarterly earnings of $2.63 per share, beating the Zacks Consensus Estimate of $1.92 per share. This compares to earnings of $3.67 per share a year ago.

news source

Zacks Investment Research • Nov 5, 2026

news preview

Teleflex Announces Third Quarter 2026 Earnings Conference Call Information

WAYNE, Pa.--(BUSINESS WIRE)--Teleflex Incorporated (NYSE:TFX) will host a conference call to discuss its third quarter financial results and provide an operational update at 8:00 a.m. Eastern Time on Thursday, November 5, 2026. To participate in the conference call, please utilize this link to pre-register and receive the dial-in information. The call can also be accessed through a live audio webcast on the company's website, teleflex.com. An audio replay of the call will be available beginning.

news source

Business Wire • Oct 22, 2026

news preview

Teleflex Announces FDA Breakthrough Device Designation for Freesolve™ Resorbable Magnesium Scaffold

WAYNE, Pa.--(BUSINESS WIRE)--Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation (BDD) for its Freesolve™ Resorbable Magnesium Scaffold (RMS) for percutaneous coronary intervention (PCI). To qualify for a BDD, device technology must address an unmet clinical need and show that it has the potential to provide for more effective treatment of life-threateni.

news source

Business Wire • Oct 22, 2026

news preview

¹ Disclosures

Get started with M1

Invest in Teleflex Incorporated

Open an M1 investment account to buy and sell Teleflex Incorporated commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in TFX on M1